1 / 24

Post Herpetic Neuralgia

Post Herpetic Neuralgia. Stephen May. Introduction. "O’er ladies’ lips, who straight on kisses dream;Which oft the angry Mab with blisters plagues." Romeo and Juliet (W. Shakespeare).

mabyn
Télécharger la présentation

Post Herpetic Neuralgia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Post Herpetic Neuralgia Stephen May

  2. Introduction • "O’er ladies’ lips, who straight on kisses dream;Whichoft the angry Mab with blisters plagues." • Romeo and Juliet (W. Shakespeare). • "Whether or not the unknown infectious material of chickenpoxcould under certain circumstances manifest itself instead asa zoster eruption." • James von Bokay 1892.

  3. Introduction • Smallpox and chickenpox different • 1904 Ernest Tyzzer • Zoster fluid could infect with varicella • 1925 Kundratitz • Weller et al in 1958 : same virus responsible for both • Hope-Simpson : zoster is due to varicella virus reactivation

  4. Introduction • PHN is one of the most painful neuropathic conditions • Usually VZV reactivation • PHN : 1-6 mth post acute HZ • Risk increases with age • Usually a single unilateral dermatome • Thoracic and V1 most common

  5. Pathophysiology • Acute infection : necrotising reaction in dorsal horn • Large myelinated fibres are most extensively damaged • Increased transfer at dorsal horn from smaller fibres (nociceptive info) • Reduced innervation noted at affected skin • Changes evident in CNS

  6. Pathophysiology • PHN – 2 types of pain • Steady, aching, boring pain • Paroxysmal lancing pain • Allodynia, hyperalgesia, hyperaesthesia often occur • Explained by 2 different mechanisms

  7. Pathophysiology • Sensitisation • Acute injury -> ongoing discharge and hyperexcitability of nociceptor (peripheral sensitisation) • Prolonged nociceptor discharge -> enhanced dorsal horn response to afferent neurones with expansion of receptive field (central sensitisation) • Explains allodynia without marked sensory loss

  8. Pathophysiology • Deafferentation • VZV reactivation in DRG ->inflammation -> neural damage and oedema • Reduced endoneurial blood flow (↑P) • Neural destruction • Loss of afferent neurones -> spontaneous activity in deafferenated central neurones • Constant pain in area of sensory loss and minimal allodynia

  9. Pathophysiology Reactive sprouting of spinal terminals of AB mechanoreceptors to receptors formerly occupied by C-fibres results in hyperalgesia and allodynia

  10. Pathophysiology 3 subtypes • Irritable nociceptor subtype Damaged primary afferent nociceptors responsible for allodynia Little deficit in sensory thresholds as sensory signalling still occurs

  11. Pathophysiology 2) Deafferenated allodynic subtype Primary afferents more extensively damaged C fibres develop neuromata (spont discharge) -> dorsal horn sensitisation Selective loss of C fibres (touch preserved) Surviving AB fibres discharge normally -> light touch signalling pain

  12. Pathophysiology 2) Deafferenated non-allodynic subtype V. Extensive nerve damage Skin insensitive to all modalities Pain as a consequence of central sensitisation and neuronal reorganisation

  13. Management : Prevention • Increasing evidence for vaccination • Acts to increase cell mediated immunity • 2006 : UFDA have approved use • Amitriptyline has been suggested as prophylactic drug

  14. Management : Acute HZ • Antivirals • Corticosteroids • Standard analgesia • ? Epidural LA + steroid beneficial for pain • Possibly only short term effect and no clear evidence in reducing PHN incidence

  15. Management : PHN • Mainstay of treatment is • Anticonvulsants • Antidepressants • Opiates • Increasing evidence for lidocaine patches as first line therapy

  16. Management : PHN • TCA’s : NNT 2.3 for 50% pain relief • 30% minor SE’s, 4% more severe SE • NNH 22 (major), 3.7 (minor) • SSRI better tolerated but less effective • GONIP trial (nortriptyline v gabapentin) : similar effects on pain and sleep, gabapentin better tolerated

  17. Management : PHN • Only 2/3 taking carbamazepine or gabapentin for neuropathic pain get benefit • ? Best for lancinating or burning pain • NNT 3.9, RR 2.5 • Pregabalin may be tried where gabapentin not tolerated • ? Lamotrigine – not licensed for PHN in Europe

  18. Management : PHN • Lidocaine patch 5% • Reasonable first line choice and cost effective • NO SIGNIFICANT SYSTEMIC SE’S • Can get mild skin reaction • Shown to have central effects

  19. Management : PHN • Opiates – partially effective, not 1st line • Capsaicin –NNT 5.3 for 0.075% • Will increase pain in irritable nociceptor subgroup – contraindicated • TENS – to be effective : need sufficient innervation from normally conducting fast fibres

  20. Management : PHN • Epidural LA + Steroid • Evidence of effects on reducing pain • General consensus is of little effect on PHN development • ? Intrathecal methyprednisolone • Occasional small scale evidence for peripheral or sympathetic blocks – no RCT

  21. Management : Miscellaneous • Prostaglandin E2 • UVB in acute HZ • ? Myofascial component in resistant cases • LA + steroid local infiltration • Botulinum toxin A • Local skin excision (irritable nociceptor subgroup) • Intrathecal baclofen • Iv ATP

  22. References • 1)Bandolier. http://www.jr2.ox.ac.uk/bandolier/index.html • 2)Gabapentin for acute and chronic pain, Cochrane review 2005 • 3)Anticonvulsant drugs for acute and chronic pain, Cochrane review 2007 • 4)Kanari et al. Effectiveness of Prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster. Pain Med. 2007 Jan-Feb; 8(1): 36-40 • 5)Smith and Roberts. Sequential Medication Strategies for Post Herpetic Neuralgia : A Cost-Effectiveness Analysis. Pain 2007 Jan 19 • 6)Opstelten et al. Treatment of patients with herpes zoster by epidural injection of steroids and local anaesthetics : less pain after one month but no effect on long-term post herpetic neuralgia – a randomized trial. Ned Tijdschr Geneeskd 2006. Dec 2; 150(48) : 2649-55 • 7)Sederholm and Patterson. Zoster vaccine to prevent post herpetic neuralgia. J. Pain Palliat Care Pharmacother 2006; 20(4) : 41-2 • 8)Rotty et al. Interleukin 2 – A potential treatment option for post herpetic neuralgia. Clin Infect Dis 2006 Dec15; 43(12) : e109-10 • 9)Chen et al. Treatment of postherpetic neuralgia with intravenous administration of vitaminC.Anesth Analg.2006; 103: 1616-1617 • 10)Key Topics in Chronic Pain. Bios. Grady,Severn, Eldridge • 11)Geha et al. Brain activity for spontaneous pain of post herpetic • neuralgia and its modulation by lidocaine patch therapy. Pain 2006 • Oct 24 Article in press (corrected proof viewed online) • 12)Vister and Kwai. Salmon Calcitonin in the treatment of post • herpetic neuralgia. Anaesth Intensive Care. 2006 Oct; 34(5) : 668- • 71 • 13) Holcomb and Weinberg. A novel vaccine (zostavax) to prevent • herpes zoster and postherpetic neuralgia. J Drugs Dermatol. 2006 • Oct; 5(9): 863-6

  23. References • 14)Holodnig. Prevention of shingles by varicella zoster virus • vaccination. Expert Rev Vaccines. 2006 Aug: 5(4) : 431-43 • 15)Chandra et al. Gabapentin versus nortriptyline in post herpetic • neuralgia patients : a randomized, double-blind clinical trial – The • GONIP Trial. Int J Clin Pharmacol Ther. 2006 Aug: 44(8): 358-63 • 16)Jalali et al. Broad band ultraviolet B phototherapy in zoster patients • may reduce the incidence and severity of post herpetic neuralgia. • Photodermatol Photoimmunal Photomed. 2006 Oct;22(5) 232-7 • 17)Niv and Maltsman-Tseikhin. Post Herpetic Neuralgia : the never- • ending challenge. Pain Pract 2005 Dec; 5(4): 327-40 • 18)Humpenstall et al. Analgesic Therapy in Postherpetic Neuralgia : • A Quantitative Systematic Review. PLOS Med 2005 Jul; 2(7)e164 • 19)Weiner and Schmader. Post Herpetic Pain: More Then Sensory • Neuralgia? Pain Med 2006 May-Jun: 7(3) 243-9 • 20)Stolker et al. The PINE study of epidural steroids and local • anaesthetics to prevent postherpetic neuralgia : a randomized • controlled trial. Lancet 2006 Jan 21; 367(9506): 219-24 • 21)Amjad and Mashhood. The efficacy of local infiltration of • triamcinolone acetonide with lignocaine compared with lignocaine • alone in the treatment of postherpetic neuralgia. J Coll Physician • Surg Pak. 2005 Nov; 15(11): 683-5 • 22)Oxman et al. A vaccine to prevent herpes zoster and post herpetic • neuralgia in older adults. N Engl J Med 2005 Jun 2; 352(22): 2271- • 84 • 23)Hardy. Relief of pain in acute herpes zoster by nerve blocks and • possible prevention of post herpetic neuralgia. Canadian Journal of • Anesthesia52:186-190 (2005)

  24. References • 24)Hagashida et al. Analgesic effect of intravenous ATP on • postherpetic neuralgia in comparison with responses to intravenous • ketamine and lidocaine. J Anaesth 2005 ; 19(1): 31-5 • 25)Kumar et al. Neuraxial and sympathetic blocks in herpes zoster • and post herpetic neuralgia : an appraisal of current evisence. Reg • Anaesth Pain Med 2004 Sep-Oct; 29(5): 454-61 • 26)Davies and Galer. Review of lidocaine patch 5% studies in the • treatment of postherpetic neuralgia. Drugs 2004; 64(9): 937-47 • 27)Hsu-Tang et al. Botulinum toxin. A relieved neuropathic pain in a • case of post herpetic neuralgia. Pain Medicine Vol 6. No 1, 89-91 • 28)Peterson et al. Relief of Post Herpetic Neuralgia by Surgical • Removal of Painful Skin. Pain 98(1-2):119-26, 2002 Jul • 29)Hosny et al. Response of intractable post herpetic neuralgia to • intrathecal baclofen. Pain Physician : 2004;7:345-347 • 30)Johnson and Dwarkin. Clinical Review. Treatment of Herpes • Zoster and Postherpetic Neuralgia. BMJ: 2003;32(6):748-50 • 31)Hayashida et al. Analgesic effect of intravenous ATP on post • herpetic neuralgia in comparison to responses to intravenous • ketamine and lidocaine. J. Anaesth 2005; 19(1): 31-5

More Related